fluorodeoxyglucose f18 has been researched along with regorafenib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsen, J; Cyran, CC; Eschbach, RS; Fendler, WP; Hacker, M; Havla, L; Hirner-Eppeneder, H; Ingrisch, M; Kazmierczak, PM; Moser, M; Nikolaou, K; Reiser, MF; Rominger, A; Schneider, MJ; Schuster, J; Spaeth, L | 1 |
| Charette, N; Deleporte, A; Flamen, P; Garcia, C; Guiot, T; Hendlisz, A; Paesmans, M; Vandeputte, C | 1 |
| Bang, JI; Han, SW; Jeong, SY; Kang, GH; Kim, JH; Kim, TY; Lee, KH; Lim, Y; Paeng, JC; Park, KJ | 1 |
| Agrawal, A; Pereira, M; Prakash, A; Purandare, N; Puranik, AD; Rangarajan, V; Shah, S | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and regorafenib
| Article | Year |
|---|---|
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.
Topics: Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Epigenesis, Genetic; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Patient Selection; Phenylurea Compounds; Positron-Emission Tomography; Prospective Studies; Pyridines; Research Design; Retreatment; Survival Rate; Tomography, X-Ray | 2015 |
Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Pyridines; Treatment Outcome | 2017 |
2 other study(ies) available for fluorodeoxyglucose f18 and regorafenib
| Article | Year |
|---|---|
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Colonic Neoplasms; Drug Monitoring; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Immunohistochemistry; Magnetic Resonance Angiography; Neoplasms, Experimental; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Rats; Rats, Nude | 2015 |
Regorafenib-Associated Acute Pancreatitis Diagnosed on 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Pancreatitis; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Pyridines; Young Adult | 2021 |